Cutting edge: Cardiac myosin activates innate immune responses through TLRs

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 27-31

  Zhang, Ping ^a,b   Cox, Carol J ^a   Alvarez, Kathy M ^a   Cunningham, Madeleine W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC MYOSIN; EPITOPE; LIGAND; PEPTIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 8; AUTACOID; CYTOKINE; TLR2 PROTEIN, HUMAN; TLR8 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; CYTOKINE PRODUCTION; HEART MUSCLE; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; MYOCARDITIS; PRIORITY JOURNAL; CELL LINE; GENE SILENCING; GENETICS; HEART MUSCLE CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION; TUMOR CELL LINE;

CARDIAC MYOSINS; CELL LINE; CELL LINE, TUMOR; CYTOKINES; GENE SILENCING; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MONOCYTES; MYOCARDITIS; MYOCYTES, CARDIAC; PEPTIDES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 8;

EID: 68949145035     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800861     Document Type: Article

References (29)

1. Brown, C. A., and J. B. O'Connell. 1995. Myocarditis and idiopathic dilated cardiomyopathy. Am. J. Med. 99: 309-314.
2. Caforio, A. L. P., J. H. Goldman, A. J. Haven, K. M. Baig, and W. J. McKenna. 1996. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int. J. Cardiol. 54: 157-163.
3. + T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J. Immunol. 156: 3528-3534.
4. Smith, S. C., and P. M. Allen. 1991. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147: 2141-2147.
5. Li, Y., J. S. Heuser, L. C. Cunningham, S. D. Kosanke, and M. W. Cunningham. 2006. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J. Immunol. 177: 8234-8240. (Pubitemid 44846345)
6. Rose, N. R. 2000. Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat. Med. 6: 631-632.
7. Eriksson, U., R. Ricci, L. Hunziker, M. O. Kurrer, G. Y. Oudit, T. H. Watts, I. Sonderegger, K. Bachmaier, M. Kopf, and J. M. Penninger. 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9: 1484-1490.
8. Marty, R. R., S. Dirnhofer, N. Mauermann, S. Schweikert, S. Akira, L. Hunziker, J. M. Penninger, and U. Eriksson. 2006. MyD88 signaling controls autoimmune myocarditis induction. Circulation 113: 258-265.
9. Fairweather, D., S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose. 2006. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1β, and immune complex deposition in the heart. J. Immunol. 176: 3516-3524.
10. Fairweather, D., S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, R. A. Steele, S. J. Gatewood, and N. R. Rose. 2005. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-γ and macrophage and neutrophil populations in the heart. J. Immunol. 174: 261-269.
11. Shioji, K., C. Kishimoto, and S. Sasayama. 2001. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells. Circ. Res. 89: 540-546. (Pubitemid 34132648)
12. Fairweather, D., and N. R. Rose. 2005. Inflammatory heart disease: a role for cytokines. Lupus 14: 646-651.
13. Li, Y., J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham. 2004. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J. Immunol. 172: 3225-3234.
14. Eriksson, U., M. O. Kurrer, N. Schmitz, S. C. Marsch, A. Fontana, H. P. Eugster, and M. Kopf. 2003. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 107: 320-325.
15. Kubota, T., C. F. McTiernan, C. S. Frye, S. E. Slawson, B. H. Lemster, A. P. Koretsky, A. J. Demetris, and A. M. Feldman. 1997. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ. Res. 81: 627-635.
16. Rifkin, I. R., E. A. Leadbetter, L. Busconi, G. Viglianti, and A. Marshak-Rothstein. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204: 27-42.
17. Fairweather, D., S. Yusung, S. Frisancho, M. Barrett, S. Gatewood, R. Steele, and N. R. Rose. 2003. IL-12 receptor β1 and Toll-like receptor 4 increase IL-1β- and IL-18-associated myocarditis and coxsackievirus replication. J. Immunol. 170: 4731-4737.
18. Galvin, J. E., M. E. Hemric, S. D. Kosanke, S. M. Factor, A. Quinn, and M. W. Cunningham. 2002. Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am. J. Pathol. 160: 297-306.
19. Neu, N., N. R. Rose, K. W. Beisel, A. Herskowitz, G. Gurri-Glass, and S. W. Craig. 1987. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139: 3630-3636.
20. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
21. Kanzler, H., F. J. Barrat, E. M. Hessel, and R. L. Coffman. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13: 552-559.
22. Cunningham, M. W., S. M. Antone, J. M. Gulizia, B. M. McManus, V. A. Fischetti, and C. J. Gauntt. 1992. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc. Natl. Acad. Sci. USA 89: 1320-1324.
23. Krisher, K., and M. W. Cunningham. 1985. Myosin: a link between streptococci and heart. Science 227: 413-415.
24. Cunningham, M. W., and R. A. Swerlick. 1986. Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J. Exp. Med. 164: 998-1012.
25. Pahlman, L. I., M. Morgelin, J. Eckert, L. Johansson, W. Russell, K. Riesbeck, O. Soehnlein, L. Lindbom, A. Norrby-Teglund, R. R. Schumann, et al. 2006. StreptococcalMprotein: a multipotent and powerful inducer of inflammation. J. Immunol. 177: 1221-1228.
26. McNamara, C., A. S. Zinkernagel, P. Macheboeuf, M. W. Cunningham, V. Nizet, and P. Ghosh. 2008. Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science 319: 1405-1408.
27. Means, T. K., E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
28. Vollmer, J., S. Tluk, C. Schmitz, S. Hamm, M. Jurk, A. Forsbach, S. Akira, K. M. Kelly, W. H. Reeves, S. Bauer, and A. M. Krieg. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202: 1575-1585.
29. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. 4: 469-478.